6 Meridian’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q3 | – | Sell |
-8,157
| Closed | -$349K | – | 516 |
|
2021
Q2 | $349K | Buy |
8,157
+7
| +0.1% | +$299 | 0.03% | 214 |
|
2021
Q1 | $340K | Buy |
8,150
+1,798
| +28% | +$75K | 0.03% | 216 |
|
2020
Q4 | $296K | Buy |
6,352
+155
| +3% | +$7.22K | 0.03% | 213 |
|
2020
Q3 | $263K | Buy |
+6,197
| New | +$263K | 0.03% | 210 |
|
2018
Q3 | – | Sell |
-2,946
| Closed | -$223K | – | 524 |
|
2018
Q2 | $223K | Buy |
+2,946
| New | +$223K | 0.02% | 397 |
|